171 related articles for article (PubMed ID: 22236581)
1. Assessment of appropriate medication administration for hospitalized patients with Parkinson's disease.
Hou JG; Wu LJ; Moore S; Ward C; York M; Atassi F; Fincher L; Nelson N; Sarwar A; Lai EC
Parkinsonism Relat Disord; 2012 May; 18(4):377-81. PubMed ID: 22236581
[TBL] [Abstract][Full Text] [Related]
2. Medication management in people with Parkinson's disease during surgical admissions.
Derry CP; Shah KJ; Caie L; Counsell CE
Postgrad Med J; 2010 Jun; 86(1016):334-7. PubMed ID: 20547599
[TBL] [Abstract][Full Text] [Related]
3. Adherence to antiparkinson medication in a multicenter European study.
Grosset D; Antonini A; Canesi M; Pezzoli G; Lees A; Shaw K; Cubo E; Martinez-Martin P; Rascol O; Negre-Pages L; Senard A; Schwarz J; Strecker K; Reichmann H; Storch A; Löhle M; Stocchi F; Grosset K
Mov Disord; 2009 Apr; 24(6):826-32. PubMed ID: 19191340
[TBL] [Abstract][Full Text] [Related]
4. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
[TBL] [Abstract][Full Text] [Related]
5. A multicenter, open-label, sequential study comparing preferences for carbidopa-levodopa orally disintegrating tablets and conventional tablets in subjects with Parkinson's disease.
Nausieda PA; Pfeiffer RF; Tagliati M; Kastenholz KV; DeRoche C; Slevin JT
Clin Ther; 2005 Jan; 27(1):58-63. PubMed ID: 15763606
[TBL] [Abstract][Full Text] [Related]
6. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
Jost WH; Klasser M; Reichmann H
Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
[TBL] [Abstract][Full Text] [Related]
7. Medication adherence and associated outcomes in medicare health maintenance organization-enrolled older adults with Parkinson's disease.
Kulkarni AS; Balkrishnan R; Anderson RT; Edin HM; Kirsch J; Stacy MA
Mov Disord; 2008 Feb; 23(3):359-65. PubMed ID: 18074366
[TBL] [Abstract][Full Text] [Related]
8. A hospital-based study: risk factors in development of motor complications in 555 Parkinson's patients on levodopa therapy.
Benbir G; Ozekmekçi S; Apaydin H; Delil S; Erginöz E
Clin Neurol Neurosurg; 2006 Dec; 108(8):726-32. PubMed ID: 16564615
[TBL] [Abstract][Full Text] [Related]
9. Missing dosages and neuroleptic usage may prolong length of stay in hospitalized Parkinson's disease patients.
Martinez-Ramirez D; Giugni JC; Little CS; Chapman JP; Ahmed B; Monari E; Wagle Shukla A; Hess CW; Okun MS
PLoS One; 2015; 10(4):e0124356. PubMed ID: 25884484
[TBL] [Abstract][Full Text] [Related]
10. Drug adherence in Parkinson's disease.
Leopold NA; Polansky M; Hurka MR
Mov Disord; 2004 May; 19(5):513-7. PubMed ID: 15133814
[TBL] [Abstract][Full Text] [Related]
11. Assessment of a safety enhancement to the hospital medication reconciliation process for elderly patients.
Gizzi LA; Slain D; Hare JT; Sager R; Briggs F; Palmer CH
Am J Geriatr Pharmacother; 2010 Apr; 8(2):127-35. PubMed ID: 20439062
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and cost of medication nonadherence in Parkinson's disease: evidence from administrative claims data.
Davis KL; Edin HM; Allen JK
Mov Disord; 2010 Mar; 25(4):474-80. PubMed ID: 20131374
[TBL] [Abstract][Full Text] [Related]
13. Levodopa improves time-based prospective memory in Parkinson's disease.
Costa A; Peppe A; Brusa L; Caltagirone C; Gatto I; Carlesimo GA
J Int Neuropsychol Soc; 2008 Jul; 14(4):601-10. PubMed ID: 18577289
[TBL] [Abstract][Full Text] [Related]
14. Addressing delays in medication administration for patients transferred from the hospital to the nursing home: a pilot quality improvement project.
Ward KT; Bates-Jensen B; Eslami MS; Whiteman E; Dattoma L; Friedman JL; DeCastro Mariano J; Moore AA
Am J Geriatr Pharmacother; 2008 Oct; 6(4):205-11. PubMed ID: 19028376
[TBL] [Abstract][Full Text] [Related]
15. [Shifting to subcutaneous infusion of apomorphine in advanced Parkinson's disease patients on an out-patient basis: experience and recommendations].
Castaño B; Mateo D; Giménez-Roldán S
Neurologia; 2007 Apr; 22(3):133-7. PubMed ID: 17364250
[TBL] [Abstract][Full Text] [Related]
16. Adherence to topical glaucoma medication during hospitalization.
Yousuf SJ; Jones LS
J Glaucoma; 2011 Dec; 20(9):573-6. PubMed ID: 21048511
[TBL] [Abstract][Full Text] [Related]
17. Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease.
Happe S; Tings T; Helmschmied K; Neubert K; Wuttke W; Paulus W; Trenkwalder C
Mov Disord; 2004 Dec; 19(12):1511-5. PubMed ID: 15390061
[TBL] [Abstract][Full Text] [Related]
18. The use of nationwide on-line prescription records improves the drug history in hospitalized patients.
Glintborg B; Poulsen HE; Dalhoff KP
Br J Clin Pharmacol; 2008 Feb; 65(2):265-9. PubMed ID: 17764470
[TBL] [Abstract][Full Text] [Related]
19. Assessing the accuracy of computerized medication histories.
Kaboli PJ; McClimon BJ; Hoth AB; Barnett MJ
Am J Manag Care; 2004 Nov; 10(11 Pt 2):872-7. PubMed ID: 15609741
[TBL] [Abstract][Full Text] [Related]
20. Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset.
Diederich NJ; Moore CG; Leurgans SE; Chmura TA; Goetz CG
Arch Neurol; 2003 Apr; 60(4):529-33. PubMed ID: 12707066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
